CN102988403A - Injection medicine composition used for treating facial paralysis in acute stage - Google Patents
Injection medicine composition used for treating facial paralysis in acute stage Download PDFInfo
- Publication number
- CN102988403A CN102988403A CN2012105490169A CN201210549016A CN102988403A CN 102988403 A CN102988403 A CN 102988403A CN 2012105490169 A CN2012105490169 A CN 2012105490169A CN 201210549016 A CN201210549016 A CN 201210549016A CN 102988403 A CN102988403 A CN 102988403A
- Authority
- CN
- China
- Prior art keywords
- medicine composition
- facial paralysis
- acute stage
- injection medicine
- composition used
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses an injection medicine composition used for treating facial paralysis in acute stage, mainly comprising dexamethasone, anisodamine, cobamamide and lidocaine. The injection medicine composition disclosed by the invention has the effects of improving nutrition and metabolism of nervous tissues of the face, improving nutrition of local tissues, resisting inflammation and improving microcirculation. The therapeutic method has the advantages of high curative effect, available raw materials, low price and easy operation. The injection medicine composition disclosed by the invention is injected once every day, one treatment course comprises seven days (treating for 6 days and resting for 1 day), and generally a patient suffering from the facial paralysis in the acute stage can be healed for 2-3 treatment courses. Clinical verifications show that the effective rate reaches up to more than 98.4%.
Description
Affiliated technical field
The technology of the present invention relates to the drug regimen for the treatment of the acute stage facial paralysis, specifically a kind of by 4 kinds of drug regimens formulated and to acute stage facial paralysis the drug regimen of obvious therapeutic action is arranged.
Background technology
Acute stage,, facial paralysis was the outpatient service commonly encountered diseases, and sickness rate is high and be difficult to cure.Because its pathogeny is complicated, the cause of disease is still not clear so far, and its treatment has become a clinical difficult problem, and many medical personnels and scientific research personnel try to explore.At present commonly used have a following Therapeutic Method: Chinese medicine, and acupuncture, etc., oral antiviral and vitamin, hormone medicine, but curative effect is all not bery definite.Often therapeutic process is complicated, and treatment cycle is long, causes very large misery to patient, and the expected value that patient's an urgent demand is cured is very high.Actively seeking a kind of true and reliable Therapeutic Method is the direction that we make great efforts.
Summary of the invention;
The object of the present invention is to provide a kind of injectable drug combination that can effectively treat the acute stage facial paralysis that has 4 kinds of drug regimens to form.
The object of the present invention is achieved like this, and drug regimen has following several; Anisodamine, dexamethasone, cobamamide, lignocaine, 5ml oral cavity special syringe form.Using method: with sucking behind the said medicine mix homogeneously in the special syringe of 5ml oral cavity, be expelled to Ipsilateral after the partly sterilised and lead nebula wind scoop place, positive cave, bring into play its therapeutical effect, generally weekly 6 times, 7 days is a course for the treatment of.
The present invention compared with prior art is the effective method for the treatment of at present the acute stage facial paralysis.Its ingredients namely can be removed its symptom again for the cause of disease.Because it is drawn materials conveniently, simple to operate, drug price is cheap, and determined curative effect is reliable.Through our treatment totally 2000 many cases clinical verifications, effective percentage reaches more than 98.4%, and basic the healing welcome by extensive patients deeply.
The specific embodiment
1 Anisodamine 10mg, dexamethasone 10mg, cobamamide 1.0mg, lignocaine 1ml, the special-purpose needle tubing in 5ml oral cavity are for subsequent use.
2 operational approach: with mix homogeneously in each a suction needle tubing of said medicine, the strong side of order head deflection is behind the iodophor disinfection with the 5ml syringe, be injected at respectively and lead positive cave and nebula wind scoop, the nebula wind scoop thrusts a little, keeps straight on to thrust 2.5 centimeters, nearly stylomastoid foramen place behind the resorption depletion of blood, is injected at Ipsilateral nebula wind scoop place.Inject every day 1 time, 7 days is a course for the treatment of, (treat and had a rest 1 day in 6 days) general 2-3 course for the treatment of, can cure.
3 therapeutic evaluatioies and effect: the facial expression myokinesis is symmetrical, and this therapy is treated 2000 many cases altogether in order to cure, the basic healing, and total effective rate reaches more than 98.4%.
Claims (2)
1. one kind has 4 kinds of ingredients, is used for the treatment of the method for the injectable drug combination of acute stage facial paralysis:
2. said above drug regimen and implement to finish with following method according to claim 1:
The weighting profit requires all medicines of 1 to suck in the special syringes of 5ml oral cavity, is expelled to respectively that Ipsilateral leads positive cave and the nebula wind scoop gets final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105490169A CN102988403A (en) | 2012-12-06 | 2012-12-06 | Injection medicine composition used for treating facial paralysis in acute stage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105490169A CN102988403A (en) | 2012-12-06 | 2012-12-06 | Injection medicine composition used for treating facial paralysis in acute stage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102988403A true CN102988403A (en) | 2013-03-27 |
Family
ID=47917831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012105490169A Pending CN102988403A (en) | 2012-12-06 | 2012-12-06 | Injection medicine composition used for treating facial paralysis in acute stage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102988403A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024051845A1 (en) * | 2022-09-09 | 2024-03-14 | 北京达尔文细胞生物科技有限公司 | Pharmaceutical composition for preventing and treating sequelae stage facial nerve paralysis, and use thereof |
-
2012
- 2012-12-06 CN CN2012105490169A patent/CN102988403A/en active Pending
Non-Patent Citations (3)
| Title |
|---|
| 冯立新: "穴位注射临床应用举隅", 《江西中医药》 * |
| 张俊庭: "《中国中医特治新法大全》", 31 December 1996 * |
| 褚韩生等: "中西医结合治疗周围性面神经麻痹24例", 《现代中西医结合杂志》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024051845A1 (en) * | 2022-09-09 | 2024-03-14 | 北京达尔文细胞生物科技有限公司 | Pharmaceutical composition for preventing and treating sequelae stage facial nerve paralysis, and use thereof |
| WO2024051844A1 (en) * | 2022-09-09 | 2024-03-14 | 北京达尔文细胞生物科技有限公司 | Pharmaceutical composition for preventing and treating acute stage facial nerve paralysis and use thereof |
| WO2024051847A1 (en) * | 2022-09-09 | 2024-03-14 | 北京达尔文细胞生物科技有限公司 | Pharmaceutical composition for preventing and treating facial nerve micro-entrapment syndrome and use thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101647917A (en) | Traditional Chinese medicine externally-applied anaesthetic | |
| Tao et al. | Case of professor Xu ZOU's acupuncture technique for “benefiting kidney and strengthening anti-pathogenic qi” in promoting the absorption of COVID-19 | |
| CN102198091B (en) | Acupuncture point injection | |
| CN102988403A (en) | Injection medicine composition used for treating facial paralysis in acute stage | |
| CN101829182B (en) | Medicament for treating prostatic diseases | |
| CN103417622A (en) | Stasis-reducing and venation-flowing medicated wine | |
| CN101156942A (en) | Medicine combination for treating relapse stomatocace and chronic pharyngitis | |
| CN101607017A (en) | A kind of oral Chinese medicine for the treatment of fracture | |
| CN103263333A (en) | Lung cancer metastasis therapy apparatus | |
| Data | Acupuncture plus point-injection for 32 cases of obstinate urticaria | |
| CN101336992B (en) | Traditional Chinese medicine preparation for treating early burn or scald | |
| CN102343038A (en) | Medicament for treating cerebrosis such as hemiplegic cerebral palsy, falling sickness, Parkinson, headache, insomnia and the like | |
| CN1660256A (en) | Medication for treating cough caused by inflammation of upper respiratory tract | |
| CN101904928A (en) | Ointment for treating psoriasis | |
| CN102935088A (en) | Injection therapy and drug constitutes for curing recurrent aphthous ulcer | |
| CN1214808C (en) | Pills for promoting reunion of bone, muscle and ligament | |
| CN101530448A (en) | External Chinese medicinal plaster for treating traumatic injury | |
| CN1935187B (en) | Injectionagent for treating mammary gland proliferation | |
| CN103405485A (en) | Chinese medicine injection for treating allergic rhinitis | |
| CN1526430A (en) | Fracture setting medicine powder and its prepn process | |
| CN111281961A (en) | Ointment | |
| CN1679572A (en) | Medicinal injection for treating primary mimic tic | |
| CN1679588A (en) | Medicinal composition for treating mimic tic | |
| CN1223370C (en) | Medicine for treating inner, external haemorrhoids and its processing method | |
| CN102764289A (en) | Externally applied medicine for treating single poisonous wasp sting |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130327 |